Leonardo DRS (DRS) EVP disposes 11,420 shares via 10b5-1 plan

Rhea-AI Filing Summary

John Baylouny, Executive Vice President and Chief Operating Officer of Leonardo DRS, reported a planned sale of company stock. On 09/17/2025 he disposed of 11,420 shares of common stock at $41.78 per share under a pre-established Rule 10b5-1 trading plan adopted May 13, 2025. Following the sale, the filing shows he beneficially owns 114,488 shares, held directly. The report was signed by attorney-in-fact Katherine Krebel on 09/18/2025. The Form 4 records a routine, prearranged insider sale rather than an open-market discretionary trade.

Positive

• Transaction executed under a Rule 10b5-1 plan, which signals prearranged trading and reduces the likelihood of trading on undisclosed material information
• Significant retained ownership after the sale (114,488 shares), indicating continued alignment with shareholders

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider sold shares via a pre-set 10b5-1 plan; ownership remains substantial and the transaction appears routine.

The sale of 11,420 shares at $41.78 under a 10b5-1 plan indicates the reporting person followed a pre-established program, reducing the likelihood that this transaction reflects new material nonpublic information. The remaining reported direct ownership of 114,488 shares represents continued substantial ownership by an executive. Absent additional context (e.g., percentage of total shares outstanding or recent company events), this filing is a routine disclosure of insider liquidity rather than a material governance or operational development.

Corporate Governance Expert

TL;DR: Transaction documents compliance with insider trading rules; signature by attorney-in-fact is standard practice.

The Form 4 documents that the sale was executed pursuant to a Rule 10b5-1 plan adopted May 13, 2025, which is a common mechanism for insiders to schedule transactions. The form is properly executed by an attorney-in-fact, which is an accepted procedural practice. There is no indication in this filing of amendment or corrective disclosure, and the filing contains the essential elements required for Section 16 reporting: relationship, transaction date, amount sold, price, and resulting beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Baylouny John

(Last) (First) (Middle)

C/O LEONARDO DRS, INC.

2345 CRYSTAL DRIVE

(Street)

ARLINGTON VA 22202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Leonardo DRS, Inc. [ DRS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and COO

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		S(1)		11,420	D	$41.78	114,488	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2025.

Remarks:

	/s/ Katherine Krebel, Attorney-in-Fact	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Leonardo DRS (DRS) disclose on this Form 4?

The filing reports that EVP and COO John Baylouny sold 11,420 shares of common stock on 09/17/2025 at $41.78 per share.

Was the sale by John Baylouny part of a prearranged plan?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2025.

How many shares does John Baylouny beneficially own after the transaction?

Following the reported transaction, the Form 4 shows he beneficially owns 114,488 shares, held directly.

Who signed the Form 4 and when was it filed?

The document is signed by attorney-in-fact Katherine Krebel on 09/18/2025 as the filing signature for the reporting person.

Does this Form 4 indicate any amendment or corrective filing?

No. The form does not show an amendment date; the provided filing indicates an original Form 4 reporting the transaction.